The Cannabis Dilemma: A Review of Its Associated Risks and Clinical Efficacy

المؤلفون المشاركون

Zhang, Melvyn Weibin
Ho, Roger C. M.

المصدر

Journal of Addiction

العدد

المجلد 2015، العدد 2015 (31 ديسمبر/كانون الأول 2015)، ص ص. 1-6، 6ص.

الناشر

Hindawi Publishing Corporation

تاريخ النشر

2015-10-11

دولة النشر

مصر

عدد الصفحات

6

التخصصات الرئيسية

علم الاجتماع
الصحة العامة

الملخص EN

Cannabis, also known as marijuana, has 9-tetrahydrocannabinol as the main constituent.

There has been strict legislation governing the utilization of cannabis locally and worldwide.

However, there has been an increasing push to make cannabis legalized, in view of its potential medical and therapeutic effects, for various medical disorders ranging from development disorders to cancer treatment, and being an adjunctive medication for various neurological conditions.

It is the aim of this review paper to explore the evidence base for its proposed therapeutic efficacy and to compare the evidence base supporting its proposed therapeutic efficacy with its known and well-researched medical and psychiatric side effects.

نمط استشهاد جمعية علماء النفس الأمريكية (APA)

Zhang, Melvyn Weibin& Ho, Roger C. M.. 2015. The Cannabis Dilemma: A Review of Its Associated Risks and Clinical Efficacy. Journal of Addiction،Vol. 2015, no. 2015, pp.1-6.
https://search.emarefa.net/detail/BIM-1067026

نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)

Zhang, Melvyn Weibin& Ho, Roger C. M.. The Cannabis Dilemma: A Review of Its Associated Risks and Clinical Efficacy. Journal of Addiction No. 2015 (2015), pp.1-6.
https://search.emarefa.net/detail/BIM-1067026

نمط استشهاد الجمعية الطبية الأمريكية (AMA)

Zhang, Melvyn Weibin& Ho, Roger C. M.. The Cannabis Dilemma: A Review of Its Associated Risks and Clinical Efficacy. Journal of Addiction. 2015. Vol. 2015, no. 2015, pp.1-6.
https://search.emarefa.net/detail/BIM-1067026

نوع البيانات

مقالات

لغة النص

الإنجليزية

الملاحظات

Includes bibliographical references

رقم السجل

BIM-1067026